152 Immuno-oncology protein biomarker panels provide greater biological insights and improved patient stratification

• Nir Hacohen,
• Keith Flaherty,
• Ryan Sullivan,
• Genevieve M Boland,
• Marijana Rucevic,
• Arnav Mehta,
• Katarina Horneaus,
• Emmett Sprecher,
• Alexis Schneider,
• Russell W Jenkins,
• William Michaud,
• Benchun Miao

Affiliations

Nir Hacohen

1Broad Institute of MIT and Harvard, Cambridge, MA, USA

Keith Flaherty

Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA

Ryan Sullivan

2Massachusetts General Hospital, Boston, MA, USA

Genevieve M Boland

Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Marijana Rucevic

1Olink Proteomics, Boston, MA, USA

Arnav Mehta

2Massachusetts General Hospital, Boston, MA, USA

Katarina Horneaus

5Olink Proteomics, Uppsala, Uppsala län, Sweden

Emmett Sprecher

5Olink Proteomics, Uppsala, Uppsala län, Sweden

Alexis Schneider

6Broad Institute, Cambridge, MA, USA

Russell W Jenkins

2Massachusetts General Hospital, Boston, MA, USA

William Michaud

2Massachusetts General Hospital, Boston, MA, USA

Benchun Miao

2Massachusetts General Hospital, Boston, MA, USA